SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001867929-21-000002
Filing Date
2021-09-28
Accepted
2021-09-28 11:41:54
Documents
1
Effectiveness Date
2021-09-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8218
  Complete submission text file 0001867929-21-000002.txt   9306
Mailing Address 6100 ROYAL MOUNT AVENUE NRC BUILDING MONTREAL A8 H4P2R2
Business Address 6100 ROYALMOUNT AVENUE NRC BUILDING MONTREAL A8 H4P2R2 (416) 697-9212
Kalgene Phamaceuticals Inc. (Filer) CIK: 0001867929 (see all company filings)

IRS No.: 830005526 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-403855 | Film No.: 211285104